Form 4: Roivant Sciences CFO Richard Pulik Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Richard Pulik, CFO of Roivant Sciences, reports a transaction involving the net settlement of Restricted Stock Units (RSUs) to cover tax obligations.
Summary
- On April 28, 2025, Richard Pulik, the CFO of Roivant Sciences Ltd., reported a transaction on SEC Form 4.
- The transaction involved the net settlement of 1,653 common shares at a price of $11.19 to satisfy tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- Following the transaction, Pulik directly owns 405,699 common shares.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, which is neither particularly positive nor negative. It's a neutral event in the context of the company's overall performance.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 04/28/2025 | Date of transaction involving common shares. |
| 04/30/2025 | Date of signature on the report. |
Keywords
Roivant Sciences, Richard Pulik, CFO, Form 4, SEC, RSU, Restricted Stock Units, Tax Withholding, Beneficial Ownership, Common Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.